Literature DB >> 8272179

Worldwide occurrence of Parkinson's disease: an updated review.

Z X Zhang1, G C Román.   

Abstract

Comparison of Parkinson's disease (PD) prevalence and incidence in various parts of the world is difficult because methods of case ascertainment, diagnostic criteria, classification, medical facilities, and age distribution of the populations vary broadly in different studies. We minimized these differences by adjusting available data to a single standard population. Using this we calculated age-adjusted rates for 27 regional populations and analyzed PD frequency from 45 communities. We conclude: (1) with the exception of China, Japan and Africa, which have the lowest prevalence ratios, the actual prevalence variation for PD is probably lower than previously reported in geographically diverse populations; (2) geographic variation is unlikely to be due exclusively to racial factors, and (3) environmental risk factors for PD might differ regionally.

Entities:  

Mesh:

Year:  1993        PMID: 8272179     DOI: 10.1159/000110318

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  41 in total

Review 1.  Bromocriptine for levodopa-induced motor complications in Parkinson's disease.

Authors:  J J van Hilten; C Ramaker; W J Van de Beek; M J Finken
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 2.  Estrogen as neuroprotectant of nigrostriatal dopaminergic system: laboratory and clinical studies.

Authors:  Dean Dluzen; Martin Horstink
Journal:  Endocrine       Date:  2003-06       Impact factor: 3.633

Review 3.  Late-stage Parkinson disease.

Authors:  Miguel Coelho; Joaquim J Ferreira
Journal:  Nat Rev Neurol       Date:  2012-07-10       Impact factor: 42.937

Review 4.  Parkinson's disease.

Authors:  Carl E Clarke; A Peter Moore
Journal:  BMJ Clin Evid       Date:  2007-08-01

5.  Minority enrollment in Parkinson's disease clinical trials.

Authors:  Myra G Schneider; Christopher J Swearingen; Lisa M Shulman; Jian Ye; Mona Baumgarten; Barbara C Tilley
Journal:  Parkinsonism Relat Disord       Date:  2008-08-09       Impact factor: 4.891

6.  Parkinsonism in a population of northern Tanzania: a community-based door-to-door study in combination with a prospective hospital-based evaluation.

Authors:  Andrea Sylvia Winkler; Esra Tütüncü; Anna Trendafilova; Michael Meindl; John Kaaya; Erich Schmutzhard; Jan Kassubek
Journal:  J Neurol       Date:  2009-12-19       Impact factor: 4.849

Review 7.  How far are we in understanding the cause of Parkinson's disease?

Authors:  Y Ben-Shlomo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

Review 8.  Oxidative damage to macromolecules in human Parkinson disease and the rotenone model.

Authors:  Laurie H Sanders; J Timothy Greenamyre
Journal:  Free Radic Biol Med       Date:  2013-01-15       Impact factor: 7.376

9.  Clinical characteristics of Parkinson's disease among Jewish Ethnic groups in Israel.

Authors:  R Djaldetti; S Hassin-Baer; M J Farrer; C Vilariño-Güell; O A Ross; V Kolianov; S Yust-Katz; T A Treves; Y Barhum; M Hulihan; E Melamed
Journal:  J Neural Transm (Vienna)       Date:  2008-07-30       Impact factor: 3.575

Review 10.  Prevalence of Parkinson's disease in populations of African ancestry: a review.

Authors:  Aideen McInerney-Leo; Katrina Gwinn-Hardy; Robert L Nussbaum
Journal:  J Natl Med Assoc       Date:  2004-07       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.